These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 36301211)

  • 1. Plasma tau, NfL, GFAP and UCHL1 as candidate biomarkers of alcohol withdrawal-associated brain damage: A pilot study.
    Clergue-Duval V; Vrillon A; Jeanblanc J; Questel F; Azuar J; Fouquet G; Mouton-Liger F; Rollet D; Hispard E; Bouaziz-Amar E; Bloch V; Dereux A; Cognat E; Marie-Claire C; Laplanche JL; Bellivier F; Paquet C; Naassila M; Vorspan F
    Addict Biol; 2022 Nov; 27(6):e13232. PubMed ID: 36301211
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluating the utility of serum NfL, GFAP, UCHL1 and tTAU as estimates of CSF levels and diagnostic instrument in neuroinflammation and multiple sclerosis.
    Koerbel K; Maiworm M; Schaller-Paule M; Schäfer JH; Jakob J; Friedauer L; Steffen F; Bittner S; Foerch C; Yalachkov Y
    Mult Scler Relat Disord; 2024 Jul; 87():105644. PubMed ID: 38701697
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High Levels of NfL, GFAP, TAU, and UCH-L1 as Potential Predictor Biomarkers of Severity and Lethality in Acute COVID-19.
    Salvio AL; Fernandes RA; Ferreira HFA; Duarte LA; Gutman EG; Raposo-Vedovi JV; Filho CHFR; da Costa Nunes Pimentel Coelho WL; Passos GF; Andraus MEC; da Costa Gonçalves JP; Cavalcanti MG; Amaro MP; Kader R; de Andrade Medronho R; Figueiredo CP; Amado-Leon LA; Alves-Leon SV
    Mol Neurobiol; 2024 Jun; 61(6):3545-3558. PubMed ID: 37996731
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of plasma levels of NFL, GFAP, UCHL1 and tau as Parkinson's disease biomarkers using multiplexed single molecule counting.
    Youssef P; Hughes L; Kim WS; Halliday GM; Lewis SJG; Cooper A; Dzamko N
    Sci Rep; 2023 Mar; 13(1):5217. PubMed ID: 36997567
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma UCHL1, GFAP, Tau, and NfL Are Not Different in Young Healthy Persons With Mild COVID-19 Symptoms Early in the Pandemic: A Pilot Study.
    Rogatzki MJ; Szeghy RE; Stute NL; Province VM; Augenreich MA; Stickford JL; Stickford ASL; Hanson ED; Ratchford SM
    Neurotrauma Rep; 2023; 4(1):330-341. PubMed ID: 37284701
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma Markers of Neurodegeneration Are Raised in Friedreich's Ataxia.
    Zeitlberger AM; Thomas-Black G; Garcia-Moreno H; Foiani M; Heslegrave AJ; Zetterberg H; Giunti P
    Front Cell Neurosci; 2018; 12():366. PubMed ID: 30425621
    [No Abstract]   [Full Text] [Related]  

  • 7. Plasma neurofilament light chain and glial fibrillary acidic protein predict stroke in CADASIL.
    Chen CH; Cheng YW; Chen YF; Tang SC; Jeng JS
    J Neuroinflammation; 2020 Apr; 17(1):124. PubMed ID: 32321529
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum glial fibrillary acidic protein is a predictor of brain metastases in patients with metastatic breast cancer.
    Darlix A; Hirtz C; Mollevi C; Ginestet N; Tiers L; Jacot W; Lehmann S
    Int J Cancer; 2021 Oct; 149(8):1605-1618. PubMed ID: 34196964
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Time course and diagnostic utility of NfL, tau, GFAP, and UCH-L1 in subacute and chronic TBI.
    Shahim P; Politis A; van der Merwe A; Moore B; Ekanayake V; Lippa SM; Chou YY; Pham DL; Butman JA; Diaz-Arrastia R; Zetterberg H; Blennow K; Gill JM; Brody DL; Chan L
    Neurology; 2020 Aug; 95(6):e623-e636. PubMed ID: 32641529
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Admission levels of serum biomarkers have additive and cumulative prognostic value in traumatic brain injury.
    Kaaber IA; Lesbo M; Wichmann TO; Olsen DA; Rasmussen MM; Brink O; Borris LC; Hviid CVB
    Sci Rep; 2024 Jun; 14(1):14139. PubMed ID: 38898030
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum Tau, Neurofilament Light Chain, Glial Fibrillary Acidic Protein, and Ubiquitin Carboxyl-Terminal Hydrolase L1 Are Associated with the Chronic Deterioration of Neurobehavioral Symptoms after Traumatic Brain Injury.
    Lange RT; Lippa S; Brickell TA; Gill J; French LM
    J Neurotrauma; 2023 Mar; 40(5-6):482-492. PubMed ID: 36170576
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distribution of five clinically important neuroglial proteins in the human brain.
    Sjölin K; Kultima K; Larsson A; Freyhult E; Zjukovskaja C; Alkass K; Burman J
    Mol Brain; 2022 Jun; 15(1):52. PubMed ID: 35765081
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatic and renal function impact concentrations of plasma biomarkers of neuropathology.
    Berry K; Asken BM; Grab JD; Chan B; Lario Lago A; Wong R; Seetharaman S; LaHue SC; Possin KL; Rojas JC; Kramer JH; Boxer AL; Lai JC; VandeVrede L
    Alzheimers Dement (Amst); 2022; 14(1):e12321. PubMed ID: 35845260
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neurofilament light, glial fibrillary acidic protein, and tau in a regional epilepsy cohort: High plasma levels are rare but related to seizures.
    Akel S; Asztely F; Banote RK; Axelsson M; Zetterberg H; Zelano J
    Epilepsia; 2023 Oct; 64(10):2690-2700. PubMed ID: 37469165
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tau and neurofilament light-chain as fluid biomarkers in spinocerebellar ataxia type 3.
    Garcia-Moreno H; Prudencio M; Thomas-Black G; Solanky N; Jansen-West KR; Hanna Al-Shaikh R; Heslegrave A; Zetterberg H; Santana MM; Pereira de Almeida L; Vasconcelos-Ferreira A; Januário C; Infante J; Faber J; Klockgether T; Reetz K; Raposo M; Ferreira AF; Lima M; Schöls L; Synofzik M; Hübener-Schmid J; Puschmann A; Gorcenco S; Wszolek ZK; Petrucelli L; Giunti P
    Eur J Neurol; 2022 Aug; 29(8):2439-2452. PubMed ID: 35478426
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Integrated evaluation of a panel of neurochemical biomarkers to optimize diagnosis and prognosis in amyotrophic lateral sclerosis.
    Falzone YM; Domi T; Mandelli A; Pozzi L; Schito P; Russo T; Barbieri A; Fazio R; Volontè MA; Magnani G; Del Carro U; Carrera P; Malaspina A; Agosta F; Quattrini A; Furlan R; Filippi M; Riva N
    Eur J Neurol; 2022 Jul; 29(7):1930-1939. PubMed ID: 35263489
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined GFAP, NFL, Tau, and UCH-L1 panel increases prediction of outcomes in neonatal encephalopathy.
    Yang Z; Xu H; Sura L; Arja RD; Patterson RL; Rossignol C; Albayram M; Rajderkar D; Ghosh S; Wang K; Weiss MD
    Pediatr Res; 2023 Apr; 93(5):1199-1207. PubMed ID: 35273370
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Brain-specific biomarkers in urine as a non-invasive approach to monitor neuronal and glial damage.
    Kohlhase K; Frank F; Wilmes C; Koerbel K; Schaller-Paule MA; Miles M; Betz C; Steinmetz H; Foerch C
    Eur J Neurol; 2023 Mar; 30(3):729-740. PubMed ID: 36409153
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum and cerebrospinal fluid brain damage markers neurofilament light and glial fibrillary acidic protein correlate with tick-borne encephalitis disease severity-a multicentre study on Lithuanian and Swedish patients.
    Veje M; Griška V; Pakalnienė J; Mickienė A; Bremell D; Zetterberg H; Blennow K; Lindquist L; Studahl M
    Eur J Neurol; 2023 Oct; 30(10):3182-3189. PubMed ID: 37431060
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sex Differences in Behavioral Symptoms and the Levels of Circulating GFAP, Tau, and NfL in Patients With Traumatic Brain Injury.
    Sass D; Guedes VA; Smith EG; Vorn R; Devoto C; Edwards KA; Mithani S; Hentig J; Lai C; Wagner C; Dunbar K; Hyde DR; Saligan L; Roy MJ; Gill J
    Front Pharmacol; 2021; 12():746491. PubMed ID: 34899299
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.